image image image
image UASOM Div. Continuing Medical Education Alabama Practice-Based CME Network AQAF image
image image image
 
Home
CME
Courses
Geriatric-Focused Courses
Research
Online Resources
Literature Archives
Patient Edu. Resources
Other Resources
Networking
Forum
Membership Services
Member Registration
Literature Search Request
Medical Letter
Featured News
Membership Profile
EHR Corner
Glossary of Terms
Courses
Home > CME > Courses
Chronic Obstructive Pulmonary Disease

Certified for 1 AMA PRA Category 1 Credit

Co-Sponsored by the University of Alabama School of Medicine
Division of Continuing Medical Education and
Alabama Quality Assurance Foundation

Release Date: April 3, 2007
Expiration Date: April 3, 2010
TARGET AUDIENCE:
Primary care physicians

OBJECTIVES:
Upon completion of this CME activity, physicians and other healthcare professionals should be able to:
  • Recognize patients at risk for developing COPD.
  • Monitor the progression of COPD.
  • Add medications to treat COPD in an evidence-based step wise manner.
  • Recognize conditions that can mimic COPD exacerbations.
Top of Page

SOURCE:
FACULTY:

Terrence Shaneyfelt, MD , MPH
Assistant Professor of Medicine
University of Alabama at Birmingham

Top of Page
 
DISCLOSURE:

The faculty listed has no commercial affiliations to disclose.

Because of the nature of preliminary studies, some products mentioned are unlabeled and investigational. Dosages, indications, and methods of use of drugs mentioned in this publication may reflect the experience of the authors, clinical literature, or other resources. Therefore, please see the full prescribing information before using any licensed product mentioned.


CME PARTICIPATION:
To participate in this online course for CME credit, please review the objectives before beginning the program. Complete the course and the self-assessment test before April 5, 2010 to receive CME credit. Your certificate will then be available online. This process should take approximately 1 hour.

ACCREDITATION:

The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Alabama School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The boards of nursing in many states, including Alabama, recognize Category 1 continuing medical education courses as acceptable activities for the renewal of license to practice nursing.

Top of Page

DISCLAIMER: 
Dosages, indications, and methods of use of any drug referred to in this publication may reflect the clinical experience of the authors, clinical literature, or other clinical resources. Therefore, please see the full prescribing information before using any product mentioned. UAB is an equal opportunity/affirmative action institution.

INTRODUCTION:

Chronic obstructive pulmonary disease is a preventable and treatable disease characterized by airflow limitation that is not fully reversible. The airflow limitation is usually progressive and characterized by a mixture of small airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema).

COPD can be classified into 4 stages based on post-bronchodilator FEV1. Spirometry is essential for diagnosis and provides a description of the severity of pathologic changes in COPD.


Introduction

COPD is the 4th leading cause of death in the United States and is projected to be the 3rd leading cause of death worldwide by 2020. It is estimated that 4-6% of adult white males and 1-3% of adult white females have COPD.  These are probably underestimates as COPD is usually not diagnosed until clinically apparent and often advanced.

The economic and social burden of COPD is high. COPD expenditures for health care costs were estimated at $37.2 billion in 2004.

Because of these factors the Global Initiative for Chronic Obstructive Lung Disease has developed a program to improve the knowledge of epidemiology, socioeconomics, public health and health education of COPD (http://goldcopd.com)

The recommendations made in this CME module are based on recommendations of the GOLD Initiative [1] and a joint statement of the American Thoracic Society/European Respiratory Society.[2]

 

Top of Page

Case 1:

Mr. S is a 56-year-old male who presents to your office for a yearly check-up. He has no complaints today. He is employed as a landscaper. Prior to working as a landscaper he was employed as a painter. He smokes 1 pack of cigarettes per day for the past twenty years. He denies cough or dyspnea. Physical examination reveals no evidence of wheezing or changes in airflow on chest auscultation. You order a screening cholesterol, prostate specific antigen (per patient request), and fecal occult blood testing on three consecutive stool samples.

Top of Page

Case 1, Question 1 of 6

1. Should Patients like Mr. S. who are asymptomatic, be routinely screened for chronic obstructive pulmonary disease (COPD)?

A. Yes.
B. No.

Top of Page


 
|
|
|
|
| |
image image image
Copyright © 2006 University of Alabama School of Medicine - UAB. All rights reserved.